Marrone Bio Innovations

NASDAQ MBII
- - -%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

145.81M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

161.17M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.27
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

182.26M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-

Upcoming events Marrone Bio Innovations

All events
No upcoming events scheduled

Stock chart Marrone Bio Innovations

Stock analysis Marrone Bio Innovations

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-6.98 -5.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
4.92 2.70
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-10.94 -1.20
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-1.04 1.90
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-91.33 -50.64

Price change Marrone Bio Innovations per year

0.77$ 2.90$
Min Max

Summary analysis Marrone Bio Innovations

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Marrone Bio Innovations

Revenue and net income Marrone Bio Innovations

All parameters

About company Marrone Bio Innovations

Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which are bio fungicides that protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. The company provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Davis, California.
Address:
1540 Drew Avenue, Davis, CA, United States, 95618
Company name: Marrone Bio Innovations
Issuer ticker: MBII
ISIN: US57165B1061
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2013-08-02
Sector: Materials
Industry: Fertilizers & Agricultural Chemicals
Site: https://www.marronebio.com

On which stock exchange are Marrone Bio Innovations (MBII) stocks traded?

Marrone Bio Innovations (MBII) stocks are traded on NASDAQ.

What is the ticker of Marrone Bio Innovations stocks (MBII)?

The stock ticker of Marrone Bio Innovations’s stocks or in other words, the code is MBII. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Marrone Bio Innovations (MBII) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Marrone Bio Innovations (MBII) belongs to the «Materials» sector and the «Fertilizers & Agricultural Chemicals» industry.

In what currency are Marrone Bio Innovations (MBII) stocks traded?

Marrone Bio Innovations (MBII) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Marrone Bio Innovations (MBII) stocks today?

The current price of Marrone Bio Innovations stocks on 05.05.2024 is dollars. per share.

What is the dynamics of Marrone Bio Innovations (MBII) stocks from the beginning of the year?

Marrone Bio Innovations (MBII) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Marrone Bio Innovations (MBII) stocks increase in мае 2024?

This month Marrone Bio Innovations (MBII) quotes have increased by 0% to dollars. per share.

How much are Marrone Bio Innovations (MBII) stocks worth?

Today, on October, 05.05.2024 Marrone Bio Innovations’s (MBII) stocks cost dollars..

What is the market capitalization of Marrone Bio Innovations (MBII)?

Capitalization is the market value of Marrone Bio Innovations (MBII) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 05.05.2024, the market capitalization of Marrone Bio Innovations (MBII) is estimated at about 145808800 dollars.